PsychedelicNewsBreaks – Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) (FSE: CWY0) Selects Aegis Capital Corp. as Sole Bookrunner for $2.4M Private Placement
Clearmind Medicine (NASDAQ: CMND) (CSE: CMND) (FSE: CWY0), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, has chosen Aegis Capital Corp. to act as sole bookrunner on its registered direct and private placement. According to the announcement, the placement is valued at $2.4 million. In the wealth management and investment banking business since 1984, Aegis is focused on providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. To view the full press release, visit https://ibn.fm/YmQUC About Clearmind…